Clinical Trial Update: Efficacy and Safety of Insulin Glargine in Patients With Type 2 Diabetes With Inadequate Control on DPP-4 Inhibitor Therapy [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update reports on the efficacy and safety of insulin glargine in adults with type 2 diabetes inadequately controlled on a DPP-4 inhi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED